Published in Dig Dis Sci on February 01, 2002
Post-test calibration of single-use, antimony, 24-hour ambulatory esophageal pH probes is necessary. Dig Dis Sci (2004) 0.77
Airway-centered interstitial fibrosis: etiology, clinical findings and prognosis. Respir Res (2015) 0.76
Ingested acidic food and liquids may lead to misinterpretation of 24-hour ambulatory pH tests: focus on measurement of extra-esophageal reflux. Dig Dis Sci (2007) 0.75
Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol (1974) 5.89
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60
The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology (1994) 4.35
Patterns of gastroesophageal reflux in health and disease. Ann Surg (1976) 4.07
The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology (1998) 3.60
The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol (1988) 3.53
Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut (1988) 3.45
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96
The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol (1991) 2.91
Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion (1992) 2.40
The role of gastroesophageal reflux in chronic cough and asthma. Chest (1997) 2.25
Ambulatory monitoring of oesophageal pH in reflux oesophagitis using a portable radiotelemetry system. Gut (1982) 2.19
Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol (1997) 2.17
Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology (1996) 2.14
Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole. Chest (1999) 1.99
Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci (1999) 1.98
Reproducibility of ambulatory oesophageal pH monitoring. Gut (1988) 1.97
Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci (1988) 1.91
24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest (1999) 1.90
Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology (1987) 1.88
Esophageal 24-h pH monitoring: is prior manometry necessary for correct positioning of the electrode? Am J Gastroenterol (1990) 1.76
24-hour recording of esophageal pressure and pH in patients with noncardiac chest pain. Gastroenterology (1986) 1.75
Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. Am J Gastroenterol (1997) 1.74
Daytime gastro-oesophageal reflux is important in oesophagitis. Gut (1987) 1.72
Prolonged pH recording in the study of gastro-oesophageal reflux. Br J Surg (1969) 1.70
Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut (1987) 1.70
Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut (1987) 1.60
The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med (1999) 1.60
The role of prolonged esophageal pH monitoring in the diagnosis of gastroesophageal reflux. JAMA (1984) 1.49
The oesophagus as a cause of recurrent chest pain: which patients should be investigated and which tests should be used? Lancet (1985) 1.48
Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. Gut (1990) 1.48
A frequency-duration index (FDI) for the evaluation of ambulatory recordings of gastro-oesophageal reflux. Br J Surg (1984) 1.45
Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut (1995) 1.44
Computerized 24-hour ambulatory esophageal pH monitoring and esophagogastroduodenoscopy in the reflux patient. A comparative study. Ann Surg (1984) 1.44
Effect of sleep on swallowing, esophageal peristalsis, and acid clearance. Gastroenterology (1984) 1.41
Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain. Am J Med (1991) 1.39
Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med (1996) 1.36
One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol (1998) 1.29
Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy. Scand J Gastroenterol (1990) 1.26
Spatiotemporal characteristics of physiological gastroesophageal reflux. Am J Physiol (1994) 1.21
Twenty-four-hour esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology (1981) 1.21
Salivary secretion in reflux esophagitis. Gastroenterology (1982) 1.17
How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease? Dig Dis Sci (1995) 1.15
Comparison of esophageal manometry, provocative testing, and ambulatory monitoring in patients with unexplained chest pain. Dig Dis Sci (1990) 1.14
Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med (1999) 1.13
Influence of body position, dry and water swallows, smoking, and alcohol on esophageal acid clearing. Scand J Gastroenterol (1978) 1.10
Twenty-four hour ambulatory oesophageal pH monitoring: an update. Br J Surg (1987) 1.10
Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci (1997) 1.10
Empiric therapy for gastroesophageal reflux disease. Arch Intern Med (1995) 1.08
The cost-effectiveness of strategies to assess gastroesophageal reflux as an exacerbating factor in asthma. Am J Gastroenterol (1999) 1.08
Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut (1996) 1.08
Spontaneous noncardiac chest pain: value of ambulatory esophageal pH and motility monitoring. Dig Dis Sci (1989) 1.07
Esophageal acid perfusion, airway function, and symptoms in asthmatic patients with marked bronchial hyperreactivity. Chest (1989) 1.07
Electrodes for 24 hours pH monitoring--a comparative study. Gut (1987) 1.06
Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol (1989) 1.03
The pattern of nocturnal and diurnal esophageal acid exposure in the pathogenesis of erosive mucosal damage. Am J Gastroenterol (1994) 1.01
Prevalence of oesophagitis in asthmatics. Gut (1992) 1.00
Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci (1989) 1.00
Is long-term esophageal pH monitoring of clinical value? Am J Gastroenterol (1989) 0.98
Treatment versus management of gastroesophageal reflux disease. Am J Gastroenterol (1997) 0.97
The contribution of gastroesophageal reflux to chest pain in patients with coronary artery disease. Ann Intern Med (1992) 0.95
Rolling review: gastro-oesophageal reflux disease. Aliment Pharmacol Ther (1993) 0.95
Exertional gastro-oesophageal reflux: a mechanism for symptoms in patients with angina pectoris and normal coronary angiograms. Br Med J (Clin Res Ed) (1987) 0.94
Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther (1999) 0.92
Gastroesophageal pH step-up inaccurately locates proximal border of lower esophageal sphincter. Dig Dis Sci (1992) 0.92
24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors. Br J Surg (1999) 0.91
Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor. Aliment Pharmacol Ther (2000) 0.91
24-h pH monitoring for gastroesophageal reflux disease: already standard but not yet gold? Am J Gastroenterol (1992) 0.90
Globus pharyngeus: long-term follow-up and prognostic factors. Ann Otol Rhinol Laryngol (1991) 0.86
Ambulatory esophageal pH monitoring. Am J Med (1997) 0.86
Ambulatory esophageal manometry, pH-metry, and Holter ECG monitoring in patients with atypical chest pain. Dig Dis Sci (1993) 0.86
The ion sensitive field effect transistor (ISFET) pH electrode: a new sensor for long term ambulatory pH monitoring. Gut (1991) 0.86
Comparison of three methods of intraesophageal pH recordings in the diagnosis of gastroesophageal reflux. Scand J Gastroenterol (1988) 0.85
Anatomical diagnostic protocol in evaluating chronic cough with specific reference to gastroesophageal reflux disease. Am J Med (2000) 0.84
Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease. Dig Dis Sci (1994) 0.81
Accurate placement of the esophageal pH electrode for 24-hour pH monitoring using a combined pH/manometry probe. Am J Gastroenterol (2000) 0.81
Evaluation of gastroesophageal reflux as a cause of idiopathic hoarseness. Dig Dis Sci (1989) 0.80
[A study of post-prandial oesophageal pH in healty subjects and in patients with gastro-oesophageal reflux. Diagnostic value of a scoring index of acid reflux (author's transl)]. Gastroenterol Clin Biol (1980) 0.80
Intraesophageal pH monitoring after breakfast + lunch in gastroesophageal reflux. J Clin Gastroenterol (1988) 0.80
Failure of initial 24-hour esophageal pH monitoring to predict refractoriness and intractability in reflux esophagitis. Am J Gastroenterol (1991) 0.79
Computerized ambulatory esophageal pH monitoring in 50 asymptomatic volunteer subjects. Results and clinical implications. Am J Surg (1988) 0.78
Inclusion of supine period in short-duration pH monitoring is essential in diagnosis of gastroesophageal reflux disease. Dig Dis Sci (1996) 0.78
The LES locator: accurate placement of an electrode for 24-hour pH measurement with a combined solid state pressure transducer. Am J Gastroenterol (1992) 0.78
Cost-effectiveness of testing for gastroesophageal reflux disease: what do patients, physicians, and health insurers want? Am J Med (1999) 0.78
Aggressive acid control: minimizing progression of Barrett's esophagus. Am J Manag Care (2001) 0.75
Effect of positions, eating, and bronchodilators on gastroesophageal reflux in asthmatics. Dig Dis Sci (1990) 0.75
The diagnostic value of computerized short-term oesophageal pH-monitoring in suspected gastro-oesophageal reflux. Scand J Gastroenterol (1988) 0.75
Area under pH 4: a more sensitive parameter for the quantitative analysis of esophageal acid exposure in adults. Am J Gastroenterol (1999) 0.75
The impact of open access 24-h pH-metry on the diagnosis and management of esophageal reflux disease. Am J Gastroenterol (1999) 0.75
[Comparison of 3 methods of recording esophageal pH in the diagnosis of gastroesophageal acid reflux]. Gastroenterol Clin Biol (1984) 0.75
Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology (2006) 2.62
Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time. J Gastroenterol Hepatol (2003) 2.49
Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model. J Hepatol (2003) 1.99
Extrahepatic portal venous obstruction and obstructive jaundice: approach to management. J Gastroenterol Hepatol (2005) 1.73
Evidence for activation of cellular immune responses in patients with acute hepatitis E. Indian J Gastroenterol (2002) 1.54
Profile of liver involvement in dengue virus infection. Natl Med J India (2005) 1.27
Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study. Indian J Gastroenterol (2005) 1.20
Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol (2010) 1.17
Occult hepatitis B virus infection as a cause of cirrhosis of liver in a region with intermediate endemicity. Indian J Gastroenterol (2003) 1.11
Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol (2005) 1.08
Capsule endoscopy for obscure gastrointestinal bleeding in the tropics: report from India. Dig Endosc (2010) 1.02
Minimal hepatic encephalopathy: diagnosis by neuropsychological and neurophysiologic methods. Indian J Gastroenterol (2003) 0.98
Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics. BMC Gastroenterol (2003) 0.98
Strongyloides stercoralis infestation associated with septicemia due to intestinal transmural migration of bacteria. J Gastroenterol Hepatol (2002) 0.94
Quantification of cerebral edema on diffusion tensor imaging in acute-on-chronic liver failure. NMR Biomed (2008) 0.92
Severe ulcerative colitis: prospective study of parameters determining outcome. J Gastroenterol Hepatol (2004) 0.92
Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy. Clin Transl Gastroenterol (2015) 0.90
Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J Magn Reson Imaging (2008) 0.88
Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Am J Gastroenterol (2014) 0.87
Varicella zoster cranial polyneuropathy presenting with Dysphagia, esophagitis and gastroparesis. J Neurogastroenterol Motil (2011) 0.87
Etiological spectrum of sporadic malabsorption syndrome in northern Indian adults at a tertiary hospital. Indian J Gastroenterol (2004) 0.86
Management of childhood pancreatic disorders: a multidisciplinary approach. J Pediatr Gastroenterol Nutr (2003) 0.86
Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol (2017) 0.84
Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol (2015) 0.83
Effect of surgical portosystemic shunt on prevalence of minimal hepatic encephalopathy in children with extrahepatic portal venous obstruction: assessment by magnetic resonance imaging and psychometry. J Pediatr Gastroenterol Nutr (2010) 0.82
Encephalopathy assessment in children with extra-hepatic portal vein obstruction with MR, psychometry and critical flicker frequency. J Hepatol (2010) 0.81
Common carotid artery occlusion causing cerebral infarction in ulcerative colitis. Indian J Gastroenterol (2002) 0.78
Frequency and factors associated with increased small intestinal permeability in patients with portal hypertension. Trop Gastroenterol (2014) 0.77
TIPS can be lifesaving in acute liver failure associated with portal vein and inferior vena cava thrombosis in a case of Budd Chiari syndrome due to protein S deficiency. Cardiovasc Intervent Radiol (2007) 0.77
Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients. Nephrology (Carlton) (2017) 0.77
Unusual Presentation of Tubercular Liver Abscess in an Immune-Competent Adult. J Clin Exp Hepatol (2016) 0.75
Respiratory dysfunction is common in patients with achalasia and improves after pneumatic dilation. Dig Dis Sci (2013) 0.75
Acute Hepatitis E-Associated Acute Pancreatitis: A Single Center Experience and Literature Review. Pancreas (2015) 0.75
Acute necrotizing pancreatitis following olanzapine therapy. Trop Gastroenterol (2014) 0.75
High-resolution manometry is comparable to timed barium esophagogram for assessing response to pneumatic dilation in patients with achalasia. Indian J Gastroenterol (2015) 0.75